GBA1 and Parkinson disease: Numerous lines of research have identified lysosomal function to be a central pathway perturbed in PD [3, 57] and GWAS studies have identified heterozygous GBA variants and mutations to be present in 2–20% of PD patients from various cohorts [3, 5, 7, 58, 59].